Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00178100 · ClinicalTrials.gov registry record · Phase 4

Paroxetine and Interpersonal Psychotherapy for Maintaining Health and Well-being in Elderly Individuals With Depression

A Phase 4 study, sponsored by University of Pittsburgh.

Completed
Registry status
Phase 4
Development phase
225
Enrollment target

NCT00178100 is a Phase 4 study that has completed, run by University of Pittsburgh. The registered enrollment target is 225 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00178100, a Phase 4 study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
Phase 4
Development phase
225 participants
Enrollment target

Study Summary

This study will evaluate the effectiveness of paroxetine versus interpersonal psychotherapy and a combination of the two in helping elderly patients with depression remain well and improve quality of their lives.

Interventions

  • BEHAVIORAL Interpersonal Psychotherapy
  • DRUG paroxetine

Trial Details

FieldValue
Enrollment Target 225 participants
Start Date 1999-03
Est. Completion 2005-08
Phase Phase 4

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT00178100

The ClinicalTrials.gov registry entry for NCT00178100 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Interpersonal Psychotherapy is the first listed.

NCT00178100 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00178100 about?

NCT00178100 is a clinical study titled "Paroxetine and Interpersonal Psychotherapy for Maintaining Health and Well-being in Elderly Individuals With Depression". This study will evaluate the effectiveness of paroxetine versus interpersonal psychotherapy and a combination of the two in helping elderly patients with depression remain well and improve quality of their lives.

What is the current status of trial NCT00178100?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 225 participants. The study started on 1999-03. Estimated completion is 2005-08.

What interventions are being tested in trial NCT00178100?

The interventions under investigation include: Interpersonal Psychotherapy (BEHAVIORAL), paroxetine (DRUG).

Who is sponsoring clinical trial NCT00178100?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.